Atlas Trials

Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials

Clinical trial NCT00828919 · COMPLETED

Trial details

NCT number
NCT00828919
Sponsor
Pfizer
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Solid Tumors
Start date
2003-03-07
Primary completion
2023-08-14
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.